CUBE LABS S.P.A. - Post author:Admin
- Post published:01/06/2023
- Post category:Senza categoria
Rome, May 31, 2023 - Cube Labs S.p.A. ("Cube Labs" or "Company") - an Italian venture builder in the healthcare technology sector and listed on the Euronext Growth Milan market, Professional segment - announced the signing of a service agreement between Biodiapers Srl, a company controlled by Cube Labs S.p.A., and Sicam Srl, a historic and leading industrial operator in the national market for non-woven fabric development and absorbent technology and present, with multiple plants, in numerous countries in America, Europe, the Middle East and Asia.
Established in 2018, Biodiapers is a startup that develops cleantech absorption technologies for infants, women, and the elderly. It is majority owned by Cube Labs S.p.A., directly holding 50.4% of the share capital and indirectly holding 33.22% of the share capital through a Trust, where Cube Labs S.p.A. is the exclusive beneficiary. Biodiapers' technology is based on 100% natural nano-clay particles designed to eliminate urine and reduce the incidence of adverse skin reactions and urinary tract infections. Biodiapers' innovation lies in its use of clay and other fully biodegradable natural materials that are environmentally friendly, reducing the significant environmental impact of conventional diapers that take hundreds of years to decompose. The company holds one patent that is protected in international markets.
The agreement encompasses, professional services provided by Sicam Srl for the development of the "core" product line, targeting absorbent solutions for the elderly, women, and infants based on clay, along with the potential to explore new product opportunities in the B2B market. This includes defining the prototype, its structure, industrial designs, and determining the materials and technologies required for the production of the final industrial prototype ("core prototype").
"We are pleased to have entered into this agreement with SICAM, a prominent industrial entity that will propel the versatile and innovative solutions developed by Biodiapers towards the commercial market," commentedFilippo Surace, CEO and Founder of Cube Labs. He further stated, "We have full confidence in the commercial potential of our cleantech technologies, incorporating clay nanoparticles, which are pivotal in the development of a new generation of hypoallergenic, safe, and effective absorbent products. Additionally, the readily available and cost-effective raw materials will facilitate sustainable development with scalable production."
The agreement is valid for a period of seven months, ending on December 31, 2023, with a total value of 22,000 euros plus VAT. Its purpose is to lay the groundwork for any potential future commercial agreement that would involve the industrialization of the Core, including technology identification, pilot plant development, and subsequent marketing of the finalized industrial prototype. In anticipation of this potential agreement, contingent upon the successful completion of the aforementioned services and the creation of the "Core prototype," a budget of 70,000 euros plus VAT has already been allocated for testing the "Core prototype" at third-party testing facilities. This testing aims to develop a corresponding prototype suitable for production and commercialization.
***
This press release is available on the company's website www.cube-labs.com in the Investor Relations/Press Releases section.
***
The official text is the Italian version of the document. Any discrepancies or differences arisen in the translation are not binding and have no legal effect. In case of any dispute on the contents, the Italian original version shall always prevail.
***
Cube Labs
Cube Labs is an Italian venture builder in the healthcare technology sector created to bridge the gap between excellent academic science and the commercial Life Science market. Cube Labs creates new companies based on promising R&D activities and promotes innovation to transform pioneering science into healthcare solutions. Through its international network, Cube Labs collaborates with innovation stakeholders to transform outcomes for patients and accelerate the global transition to optimal health.
For further information, please visit the website: www.cube-labs.com.
Biodiapers
Biodiapers is a cleantech startup created by Cube Labs that utilizes a patented super-absorbent technology based on nano-clay particles to create smart absorbent products for infants, women, and the elderly. By eliminating adverse skin reactions and urinary tract infections associated with conventional products and integrating biosensors, Biodiapers is raising the standard of absorbency care. Additionally, Biodiapers is committed to reducing the significant environmental impact of conventional absorbent products by creating a line of products that are almost entirely biodegradable.
For more information, please visit the website: www.biodiapers.it
SICAM
Sicam is an Italian company that produces machinery and industrial plants in the technical textile field with over half a century of experience. Starting from traditional textiles in the 1950s, after a few years SICAM focused on non-woven fabrics with transversal experiences in their various fields of application. In fact, SICAM has consolidated technologies for decades concerning, for example, the bonding of fibers from airlay or carding, Spun Lace or Spun Bond processes, thermobonding for light veils/absorbents for medical use or diapers, spray bonding and thermosetting; Taylor made projects and complete turn-key solutions have led SICAM to compete internationally. Anticipating environmental directives and in line with current market needs, SICAM has been developing technologies for disposable plastic-free nonwovens in the medical hygiene field or made from recycled fibers for several years.
For further information consult the website: www.sicamsrl.com
| Cube Labs | ||
|
Global Media Contact Isil Guney Tel: +90 5325027243 E-mail: i.guney@cube-labs.com | MIT SIMEuronext Growth Advisor E-mail: francesca.martino@mitsim.it Tel.: +39 02 30561270 | |
| Investor Relations Vincenza Colucci E-mail: vincenza.colucci@cdr-communication.it Marika Martinciglio E-mail: marika.martinciglio@cdr-communication.it | ||
|
Ufficio Stampa Italia di Cube Labs Matteo Steinbach Cell. +393461063989 E-mail: matteo.steinbach@secnewgate.it | Federico Ziglioli Cell. +393331225959 E-mail: federico.ziglioli@secnewgate.it |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cube Labs S.p.A. published this content on 01 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2023 13:01:21 UTC.
